Integrated Wealth Concepts’s Tonix Pharmaceuticals TNXP Stock Holding History

Integrated Wealth Concepts’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92.2K	Buy	+7,224	New	+$93.2K	﹤0.01%	2877
2019 Q2	–	Hold	0	–	-$25K	–	403
2019 Q1	–	Hold	0	–	–	–	329

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments Los Angeles, California $136M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Integrated Wealth Concepts's TNXP Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 7,224 shares worth $92.2K. The stake represents ﹤0.01% of the portfolio and ranks #2877 among its holdings.

103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

Integrated Wealth Concepts held 7,224 shares of Tonix Pharmaceuticals worth $92.2K as of Q2 2026.
Tonix Pharmaceuticals was a new Integrated Wealth Concepts position in Q2 2026.
Tonix Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #2877 holding.
103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.